Loading company…
Riskpilot
← Back to search
Sign in
Get full access
DR. MISTRY AS
AS
Active
Org 823307462
Liljeveien 10A, 0586 Oslo
Medical specialists activities · NACE 8622
Est. 2019
1 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
NOK 2,7M
+4% vs 2023
EBITDA margin
37.8%
+11% vs 2023
Equity ratio
76.7%
Financial strength
Net profit 2024
NOK 789K
+10% vs 2023
EBITDA — year on year
NOK millions
1M
1M
1M
0M
0M
0M
2020
1M
+100%
2021
1M
0%
2022
1M
0%
2023
1M
0%
2024
Key figures
Annual report 2024
Revenue
NOK 2,7M
+4%
EBITDA
NOK 1M
+11%
Net profit
NOK 789K
+10%
Total assets
NOK 2,2M
+59%
Equity
NOK 1,7M
+90%
Employees
1
—
Company information
Legal name
DR. MISTRY AS
Org number
823307462
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
31. august 2019
Share capital
NOK 30 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Company purpose
Lege-, kurs- og foredragsvirksomhet samt investering og kapitalforvaltning.
Contact
Address
Liljeveien 10A, 0586 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Medical specialists activities
Companies in Oslo
All Norway companies
Revenue
NOK millions
0M
1M
2M
3M
3M
2M
2020
2M
2021
3M
2022
3M
2023
3M
2024
EBITDA
NOK millions
0M
0M
1M
1M
1M
0M
2020
1M
2021
1M
2022
1M
2023
1M
2024
Income statement
NOK thousands
Item
2020
2021
2022
2023
2024
Revenue
1 573
1 917
2 973
2 553
2 663
Staff expenses
−1 043
−1 048
−1 539
−1 598
−1 608
EBITDA
496
829
1 392
909
1 008
Depreciation & amort.
−0
−0
−0
−0
−13
EBIT
496
829
1 392
909
995
Net financials
0
−0
−0
10
17
Profit before tax
496
829
1 392
918
1 011
Tax
110
182
306
202
222
Net profit
386
647
1 085
716
789
Balance sheet
NOK thousands
Item
2020
2021
2022
2023
2024
Total assets
734
1 029
1 725
1 364
2 174
Equity
430
77
162
878
1 668
Long-term debt
0
0
0
2
3
Short-term debt
304
952
1 562
484
504
Total debt
304
952
1 562
486
506
Financial ratios
5-year trend
EBITDA margin
37.8%
This company
15.8%
Market median
+139% vs market
2020
2024
Equity ratio
76.7%
This company
38.2%
Market median
+101% vs market
2020
2024
Return on equity
47.3%
This company
18.4%
Market median
+157% vs market
2020
2024
Net profit margin
29.6%
This company
8.1%
Market median
+265% vs market
2020
2024
Asset turnover
1.23×
This company
1.12×
Market median
+10% vs market
2020
2024
Debt / equity
0.30×
This company
0.62×
Market median
+52% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (1)
NM
Nisha Mistry
Chief Executive Officer
Chief Executive Officer
2019
Board of directors
Non-executive oversight
Name
Role
Member since
Current (1)
FH
Frode Haugom
Chairman
2019
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of DR. MISTRY AS also hold positions in
0
other companies.
Person
Role here
Other companies
Nisha Mistry
Chief Executive Officer
0 companies
Frode Haugom
Chairman
0 companies